CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $73,000 | -29.8% | 3,976 | -30.1% | 0.00% | – |
| Q3 2020 | $104,000 | – | 5,692 | +94766.7% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 6 | -99.9% | 0.00% | – |
| Q3 2019 | $89,000 | -31.0% | 5,967 | -23.5% | 0.00% | – |
| Q2 2019 | $129,000 | +122.4% | 7,799 | +132.5% | 0.00% | – |
| Q1 2019 | $58,000 | -26.6% | 3,354 | -22.9% | 0.00% | – |
| Q3 2018 | $79,000 | +393.8% | 4,348 | +410.9% | 0.00% | – |
| Q2 2018 | $16,000 | -42.9% | 851 | -46.8% | 0.00% | – |
| Q1 2018 | $28,000 | +12.0% | 1,600 | -27.3% | 0.00% | – |
| Q4 2017 | $25,000 | -70.2% | 2,200 | -77.2% | 0.00% | – |
| Q2 2017 | $84,000 | – | 9,651 | +17133.9% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 56 | -61.4% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 145 | -4.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 151 | +196.1% | 0.00% | – |
| Q3 2015 | $1,000 | -85.7% | 51 | -72.9% | 0.00% | – |
| Q2 2015 | $7,000 | – | 188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 672,885 | $11,123,000 | 0.26% |
| AWM Investment Company, Inc. | 80,165 | $1,325,000 | 0.25% |
| Nikko Asset Management Americas, Inc. | 532,318 | $8,799,000 | 0.17% |
| ARK Investment Management | 314,378 | $5,197,000 | 0.13% |
| Sumitomo Mitsui Trust Holdings, Inc. | 528,418 | $8,735,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,100 | $531,000 | 0.01% |
| Mizuho Securities Co. Ltd. | 300 | $5,000 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 148,815 | $2,459,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 18,629 | $308,000 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 16,100 | $237,000 | 0.00% |